Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
A 19.75 0.00% 0.00
CBMG closed unchanged on Friday, February 19, 2021, on 1.72 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical CBMG trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Three Weeks Tight Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week High Strength 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish 0.05%
Older End-of-Day Signals for CBMG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cellular Biomedicine Group, Inc. Description

Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Cancers Stem Cells Therapeutic Product Tumor Inflammatory Disease Inflammatory Diseases Therapeutic Products Degenerative Disease Osteoarthritis Degenerative Diseases Neuron Spinal Muscular Atrophy Central Nervous System Disease Central Nervous System Diseases Progenitor Cell Tumor Cell Dendritic Cell Mesenchymal Stem Cell Stem Cell Therapy Treatment Of A Range Of Cancer Umbilical Cord Treatment Of Central Nervous System Diseases Cell Technologies Joint Disease

Is CBMG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.755
52 Week Low 11.48
Average Volume 98,232
200-Day Moving Average 17.03
50-Day Moving Average 18.65
20-Day Moving Average 19.27
10-Day Moving Average 19.73
Average True Range 0.18
ADX 35.76
+DI 34.91
-DI 14.24
Chandelier Exit (Long, 3 ATRs ) 19.22
Chandelier Exit (Short, 3 ATRs ) 18.16
Upper Bollinger Band 20.78
Lower Bollinger Band 17.76
Percent B (%b) 0.66
BandWidth 15.68
MACD Line 0.38
MACD Signal Line 0.38
MACD Histogram 0.0055
Fundamentals Value
Market Cap 384.33 Million
Num Shares 19.5 Million
EPS -2.32
Price-to-Earnings (P/E) Ratio -8.53
Price-to-Sales 1109.91
Price-to-Book 20.79
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.78
Resistance 3 (R3) 19.78 19.76 19.78
Resistance 2 (R2) 19.76 19.76 19.77 19.77
Resistance 1 (R1) 19.76 19.75 19.76 19.76 19.77
Pivot Point 19.74 19.74 19.75 19.75 19.74
Support 1 (S1) 19.74 19.74 19.74 19.74 19.73
Support 2 (S2) 19.72 19.73 19.73 19.73
Support 3 (S3) 19.72 19.72 19.73
Support 4 (S4) 19.72